UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                   FORM 8-K

                                CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


       Date of Report (Date of earliest event reported)    January 10, 2006

                          ON THE GO HEALTHCARE, INC.
            (Exact name of registrant as specified in its charter)

   DELAWARE                      333-61538                 98-0231687
---------------             --------------------    -------------------
(State or Other                 (Commission          (IRS Employer
Jurisdiction of                 File Number)           Identification
 Incorporation)                                                   No.)

                         85 Corstate Avenue, Unit #1
                              Concord, Ontario
                               Canada L4K 4Y2
              ---------------------------------------------------
              (Address of principal executive offices) (Zip Code)


     Registrant's telephone number, including area code:  (905) 760-2987

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))


ITEM 1.01  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
ITEM 2.01  COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.
ITEM 2.03  CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER
           AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

On January 10, 2006, we entered into an agreement to purchase all of the
issued and outstanding shares of Island Corporation stock in exchange
for $2,311,536 (Canadian dollars).   The purchase price was paid in a
combination of 1,060,000 shares of our restricted stock, $1,100,000 in cash
and a promissory note for $400,000.   The promissory note pays no interest
and will be paid as follows: $100,000 on or before January 20, 2006 and the
remaining $300,000 paid in twelve equal payments starting on March 31, 2006
and continuing monthly until paid in full.

The foregoing description of the terms and conditions of the acquisition and
promissory note are qualified in their entirety by, and made subject to, the
more complete information set forth in the Memorandum of Agreement and
Promissory Note attached to this Report as Exhibits 2.1 and 4.1, respectively.

<PAGE>

This  report  may  contain  forward-looking  statements  that  involve risks
and uncertainties, including, without limitation, statements  concerning
our  business  and possible or assumed future results of operations.  We
generally  use  words  such  as  "believe,"  "may," "could," "will,"
"intend,"  "expect,"  "anticipate,"  "plan," and similar expressions to
identify  forward-looking  statements.  You should not place undue reliance
on these forward-looking statements.  Our actual results could differ
materially from those anticipated in the  forward-looking  statements  for
many  reasons  including:  our ability to continue  as  a  going  concern,
adverse  economic changes affecting markets we serve;  competition  in  our
markets  and industry segments; our timing and the profitability  of
entering  new  markets; greater than expected costs, customer acceptance  of
our  products  or difficulties related to our integration of the businesses
we may acquire; and other risks and uncertainties as may be detailed from
time  to  time  in  our  public announcements and SEC filings. Although we
believe  the  expectations  reflected  in  the  forward-looking  statements
are reasonable,  they  relate  only to events as of the date on which the
statements are  made,  and  our  future  results,  levels  of  activity,
performance  or achievements may not meet these expectations.  We do not
intend to update any of the  forward-looking statements after the date of
this document to conform these statements  to  actual  results  or  to
changes  in our expectations, except as required  by  law.

<PAGE>

ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS.

(a)  Financial  statements  of  businesses  acquired:

The financial  statements  required  by this item are not included herewith and
will  be  filed  within  60  days of the required filing date of this Form 8-K.

(b)  Pro  forma  financial  information:

The  financial statements  required  by this item are not included herewith and
will  be  filed within  60  days  of the required filing date of this Form 8-K.

(c)  Exhibits:


EXHIBIT NUMBER          DESCRIPTION

2.1     Memorandum of Agreement between the Company, Norman Drolet and Ettore
        Naccarato, 2Film Technologies Inc. and Island Corporation, dated
        January 10, 2006.

4.1     Promissory Note between the Company and Norman Drolet and Ettore
        Naccarato dated January 10, 2006.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                On The Go Healthcare, Inc
Date: January 12, 2006
                                By:  /s/ Stuart Turk
                                ------------------------------------
                                Stuart Turk
                                Chief Executive Officer and President


<PAGE>
[{"type": "8-K", "sequence": "1", "filename": "island8k_jan122006.txt", "description": "ISLAND 8K DATED JAN 12, 2006", "secsgml_size_bytes": 5901}]
{"company-data": {"conformed-name": "ON THE GO HEALTHCARE INC", "cik": "0001126302", "assigned-sic": "5045", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "0731"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-61538", "film-number": "06527633"}, "business-address": {"street1": "85 CORSTATE AVENUE UNIT 1", "city": "CONCORD ONT. CANADA", "state": "A6", "zip": "L4K 4Y2", "phone": "9057602987"}}
UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                   FORM 8-K

                                CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported)    January 10, 2006

                          ON THE GO HEALTHCARE, INC.
            (Exact name of registrant as specified in its charter)

   DELAWARE                      333-61538                 98-0231687
---------------             --------------------    -------------------
(State or Other                 (Commission          (IRS Employer
Jurisdiction of                 File Number)           Identification
 Incorporation)                                                   No.)

                         85 Corstate Avenue, Unit #1
                              Concord, Ontario
                               Canada L4K 4Y2
              ---------------------------------------------------
              (Address of principal executive offices) (Zip Code)

     Registrant's telephone number, including area code:  (905) 760-2987

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

ITEM 1.01  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
ITEM 2.01  COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.
ITEM 2.03  CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER
           AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

On January 10, 2006, we entered into an agreement to purchase all of the
issued and outstanding shares of Island Corporation stock in exchange
for $2,311,536 (Canadian dollars).   The purchase price was paid in a
combination of 1,060,000 shares of our restricted stock, $1,100,000 in cash
and a promissory note for $400,000.   The promissory note pays no interest
and will be paid as follows: $100,000 on or before January 20, 2006 and the
remaining $300,000 paid in twelve equal payments starting on March 31, 2006
and continuing monthly until paid in full.

The foregoing description of the terms and conditions of the acquisition and
promissory note are qualified in their entirety by, and made subject to, the
more complete information set forth in the Memorandum of Agreement and
Promissory Note attached to this Report as Exhibits 2.1 and 4.1, respectively.
This  report  may  contain  forward-looking  statements  that  involve risks
and uncertainties, including, without limitation, statements  concerning
our  business  and possible or assumed future results of operations.  We
generally  use  words  such  as  "believe,"  "may," "could," "will,"
"intend,"  "expect,"  "anticipate,"  "plan," and similar expressions to
identify  forward-looking  statements.  You should not place undue reliance
on these forward-looking statements.  Our actual results could differ
materially from those anticipated in the  forward-looking  statements  for
many  reasons  including:  our ability to continue  as  a  going  concern,
adverse  economic changes affecting markets we serve;  competition  in  our
markets  and industry segments; our timing and the profitability  of
entering  new  markets; greater than expected costs, customer acceptance  of
our  products  or difficulties related to our integration of the businesses
we may acquire; and other risks and uncertainties as may be detailed from
time  to  time  in  our  public announcements and SEC filings. Although we
believe  the  expectations  reflected  in  the  forward-looking  statements
are reasonable,  they  relate  only to events as of the date on which the
statements are  made,  and  our  future  results,  levels  of  activity,
performance  or achievements may not meet these expectations.  We do not
intend to update any of the  forward-looking statements after the date of
this document to conform these statements  to  actual  results  or  to
changes  in our expectations, except as required  by  law.
ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS.

(a)  Financial  statements  of  businesses  acquired:

The financial  statements  required  by this item are not included herewith and
will  be  filed  within  60  days of the required filing date of this Form 8-K.

(b)  Pro  forma  financial  information:

The  financial statements  required  by this item are not included herewith and
will  be  filed within  60  days  of the required filing date of this Form 8-K.

(c)  Exhibits:

EXHIBIT NUMBER          DESCRIPTION

2.1     Memorandum of Agreement between the Company, Norman Drolet and Ettore
        Naccarato, 2Film Technologies Inc. and Island Corporation, dated
        January 10, 2006.

4.1     Promissory Note between the Company and Norman Drolet and Ettore
        Naccarato dated January 10, 2006.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                On The Go Healthcare, Inc
Date: January 12, 2006
                                By:  /s/ Stuart Turk
                                ------------------------------------
                                Stuart Turk
                                Chief Executive Officer and President